SCHEMBL31148024

SCHEMBL31148024

O=C(Nc1ccc(C2CC2)cc1)N1CCCCC1Cc1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
MAPT P10636 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
USP2 O75604 1/20 0.45
ALOX15 P16050 1/20 0.45
HSD17B10 Q99714 1/20 0.45
EPHX2 P34913 1/20 0.44
NAMPT P43490 4/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
LMNA P02545 1/20 0.41
CRACR2A Q9BSW2 1/20 0.41
JAK1 P23458 1/20 0.40
HSD11B1 P28845 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21078251 0.73 JAK1 (0.46) ALDH1A1MAPTNPC1JAK1
SCHEMBL31148163 0.73 USP2 (0.48) SMN1; SMN2USP2ALOX15HSD17B10LMNA
SCHEMBL19226472 0.72 JAK1 (0.51) ALDH1A1NPC1RAB9AJAK1
SCHEMBL21078209 0.72 KDM4E (0.47) ALDH1A1MAPTSMN1; SMN2NPC1JAK1
SCHEMBL31148136 0.71 DRD3 (0.55) ALDH1A1SMN1; SMN2USP2ALOX15HSD17B10
SCHEMBL31148132 0.71 DRD3 (0.55) ALDH1A1SMN1; SMN2USP2ALOX15HSD17B10
SCHEMBL17888457 0.70 JAK1 (0.48) ALDH1A1NPC1JAK1
SCHEMBL31148242 0.70 HRH3 (0.51) ALDH1A1MAPTSMN1; SMN2USP2ALOX15
SCHEMBL3142743 0.70 NLRP3 (0.38) MAPTSMN1; SMN2RAB9AJAK1HSD11B1
SCHEMBL31148256 0.70 HSD11B1 (0.41) ALDH1A1SMN1; SMN2USP2ALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4695236-A1 SUBSTITUTED PHENYL-PIPERAZINYL BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2026-02-18 EP disclosed
WO-2024216094-A1 SUBSTITUTED PHENYL-PIPERAZINYL BASED MODULATORS FOR THE TREATMENT OF DISEASE SOLEY THERAPEUTICS, INC. (US) 2024-10-17 WO disclosed